1034156-20-1

Basic information

• Product Name: 1-(4-fluorophenyl)-1H-indazol-5-ol
• Synonyms: 1-(4-fluorophenyl)-1H-indazol-5-ol
• CAS NO: 1034156-20-1
• Molecular Weight: 228.226
• Mol File: 1034156-20-1.mol

Chemical Properties

• CAS DataBase Reference: 1-(4-fluorophenyl)-1H-indazol-5-ol(CAS DataBase Reference)
• NIST Chemistry Reference: 1-(4-fluorophenyl)-1H-indazol-5-ol(1034156-20-1)
• EPA Substance Registry System: 1-(4-fluorophenyl)-1H-indazol-5-ol(1034156-20-1)

Safety Data

• Hazardous Substances Data: 1034156-20-1(Hazardous Substances Data)

Usage

Structure

Synthetic indazole derivative with a fluorophenyl group and a hydroxyl group attached to a five-membered indazole ring

Pharmacological properties

Interaction with the endocannabinoid system

Potential applications

Development of new drugs for various medical conditions

Research status

Further research needed to fully understand its properties and potential uses

Upstream product

• 1034155-30-0 1-(4-fluorophenyl)-5-methoxy-1H-indazole 
• 934601-20-4 1-(4-fluorophenyl)-1H-indazole-5-amine 
• 352-33-0 1-Chloro-4-fluorobenzene 
• 15579-15-4 5-hydroxy-1H-indazole 

Downstream Products

• 1035342-78-9 2-[(2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxypropan-2-yl]isoindol-1,3-dione 
• 1035342-21-2 N-((1S)-2-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-methylethyl)-2,4,6-trimethylbenzenesulfonamide 
• 1241959-86-3 1-(1-(4-fluorophenyl)-1H-indazol-5-yloxy)-1-phenylpropan-2-one 

Relevant articles and documents

CRYSTALLINE FORM OF INDAZOLYL AMIDE DERIVATIVES FOR THE TREATMENT GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS

Crystalline forms of 2,2,2-trifluoro-N-[(lR,2S)-l-[l-(4-fluorophenyl)in- dazol-5-yl]oxy-l-(3-methoxyphenyl)propan-2-yl]acetamide, processes for obtaining them, pharmaceutical intermediates used in their manu? facture, pharmaceutical compositions containing them, and their use in medical treatment.

Enantioselective synthesis of chiral β-aryloxy alcohols by ruthenium-catalyzed ketone hydrogenation via dynamic kinetic resolution (DKR)

A highly efficient enantioselective synthesis of chiral β-aryloxy alcohols by the [RuCl2[(S)-SDP][(R, R)-DPEN]} [(Sa,R, R)-1a; SDP = 7, 7′-bis-(diarylphosphino)-1,1′-spirobiindane; DPEN = trans-1,2-diphenylethylenediamine] complex-ca

INDAZOLYL SULPHONAMIDE DERIVATIVES FOR THE TREATMENT OF GLUCOCORTICOID RECEPTOR MEDIATED DISORDERS

Compounds of formula (I): [Chemical formula should be inserted here. Please see paper copy] or a pharmaceutically acceptable salt thereof; compositions comprising them, processes for preparing them and their use in medical therapy (for example modulating the glucocorticoid receptor in a warm blooded animal)